Header Nav

Press Release

« Back



AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Superconductor Technologies Inc. (STI) (Nasdaq: SCON) reported financial results for the quarter and year ended December 31, 2019.

“In March of 2020, we announced we had entered into a definitive merger agreement with Allied Integral United, Inc., also known as Clearday,” stated Jeff Quiram, STI’s President and Chief Executive Officer. “We believe the Clearday transaction has the potential to monetize our cryogenic cooler technology for shareholders. As we complete the sales of equipment and selected intellectual property primarily related to our superconducting wire initiative, we shift our complete focus to successfully finalizing the merger with Clearday.”

Merger with Clearday
On March 3, 2020, STI announced it had entered into a definitive merger agreement with Allied Integral United, Inc. (“Clearday”), a privately-held company dedicated to delivering next generation longevity care and wellness services, whereby a wholly-owned subsidiary of STI will merge with and into Clearday in a stock-for-stock transaction with Clearday.

Fourth Quarter and Full Year Financial Summary
Revenues in the fourth quarter 2019 were $388,000, $383,000 of which came from the company’s DOE NGEM project, compared to no net revenues in the fourth quarter of 2018. Net loss for the fourth quarter 2019 was $1.9 million, or a loss of $0.12 per basic and diluted share, compared to a net loss of $2.3 million, or a loss of $0.70 per basic and diluted share, in the fourth quarter of 2018.

For the year ending Dec. 31, 2019, total revenues were $545,000, compared to $1.6 million for the year ended Dec. 31, 2018. The net loss for the year 2019 was $9.2 million, or $1.23 per basic and diluted share, compared to $8.1 million, or $4.03 per basic and diluted share, for the year 2018.

Please note: share and per share data for both periods are adjusted for the 1-for-10 reverse stock split effective on July 24, 2018.

As of Dec. 31, 2019, STI had $713,000 in cash and cash equivalents.

In March of 2020, STI announced it will receive, in aggregate, approximately $1.1 million for sales of various production, R&D, and testing equipment and selected intellectual property related primarily to the company’s superconducting wire initiative. The proceeds from this series of transactions is expected to be sufficient, together with STI’s other capital resources, for the company to complete the proposed merger with Clearday.

Important Additional Information Will be Filed with the SEC
In connection with the proposed transaction between STI and Clearday, the parties intend to file relevant materials with the SEC, including a STI registration statement on Form S-4 that will contain a combined proxy statement/prospectus/information statement. INVESTORS AND STOCKHOLDERS OF STI AND CLEARDAY ARE URGED TO READ THESE MATERIALS CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT CLEARDAY, THE PROPOSED MERGER AND RELATED MATTERS. Investors and shareholders will be able to obtain free copies of the proxy statement/prospectus/information statement and other documents filed by STI with the SEC (when they become available) through the website maintained by the SEC at www.sec.gov. In addition, investors and shareholders will be able to obtain free copies of the proxy statement/prospectus/information statement and other documents filed by STI with the SEC by written request to: Superconductor Technologies Inc. 15511 W State HWY 71, Ste 110-105, Austin, TX 78738, Attention: Corporate Secretary. Investors and stockholders are urged to read the proxy statement/prospectus/information statement and the other relevant materials when they become available before making any voting or investment decision with respect to the proposed transaction.  The information in the websites of STI and Clearday is not incorporated into this press release and will not be incorporated into such SEC filed documents.

No Offer or Solicitation
This communication shall not constitute an offer to sell, the solicitation of an offer to sell or an offer to buy or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Participants in the Solicitation
STI and its directors and executive officers, and Clearday, and its directors and executive officers, may be deemed to be participants in the solicitation of proxies from the stockholders of STI in connection with the proposed merger. Information regarding the special interests of these directors and executive officers in the proposed merger will be included in the proxy statement/prospectus/information statement referred to above. Additional information about STI’s directors and executive officers is included in STI’s definitive proxy statement, filed with the SEC on April 26, 2019. These documents are available free of charge at the SEC website (www.sec.gov) and from the Corporate Secretary of STI at the address above.

Forward-Looking Statements
Any statements in this press release that are not statements of historical fact constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements regarding the proposed merger and other contemplated transactions (including statements relating to satisfaction of the conditions to and consummation of the proposed merger, the expected ownership of the combined company and opportunities relating to or resulting from the merger), and statements regarding the nature, potential approval and commercial success of Clearday and its product line, the effects of having shares of capital stock traded on the Nasdaq Capital Market, Clearday’s and the post-merger combined company’s financial resources and cash expenditures. Forward-looking statements are usually identified by the use of words such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “ideal,” “may,” “potential,” “will,” “could” and similar expressions. Actual results may differ materially from those indicated by forward-looking statements as a result of various important factors and risks. These factors, risks and uncertainties include, but are not limited to: risks relating to the completion of the merger, including the need for stockholder approval and the satisfaction of closing conditions; risks related to STI’s ability to correctly estimate and manage its operating expenses and its expenses associated with the proposed merger pending closing; the cash balances of the combined company following the closing of the merger; the ability of STI to remain listed on the Nasdaq Capital Market; the risk that as a result of adjustments to the exchange ratio, STI shareholders or Clearday stockholders could own more or less of the combined company than is currently anticipated; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed merger; the success and timing of regulatory submissions; regulatory requirements or developments; changes in capital resource requirements; and other factors discussed in the “Risk Factors” section of STI’s most recent annual report, subsequent quarterly reports and in other filings STI makes with the SEC from time to time. Risks and uncertainties related to Clearday that may cause actual results to differ materially from those expressed or implied in any forward-looking statement include, but are not limited to: Clearday’s plans to develop and commercialize its  future daily care centers and other non-residential daily care services; Clearday’s commercialization, marketing and implementation capabilities and strategy; developments and projections relating to Clearday’s competitors and its industry; the impact of government laws and regulations; and Clearday’s estimates regarding future revenue, expenses and capital requirements. In addition, the forward-looking statements included in this press release represent STI and Clearday’s views as of the date hereof. STI and Clearday anticipate that subsequent events and developments will cause their respective views to change. However, while STI and Clearday may elect to update these forward-looking statements at some point in the future, STI and Clearday specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing STI’s or Clearday’s views as of any date subsequent to the date hereof.

About Superconductor Technologies Inc. (STI)
Superconductor Technologies Inc. is a global leader in superconducting innovation. Its Conductus® superconducting wire platform offers high performance, cost-effective and scalable superconducting wire. With 100 times the current carrying capacity of conventional copper and aluminum, superconducting wire offers zero resistance with extreme high current density. This provides a significant benefit for electric power transmission and also enables much smaller or more powerful magnets for motors, generators, energy storage and medical equipment. Since 1987, STI has led innovation in HTS materials, developing more than 100 patents as well as proprietary trade secrets and manufacturing expertise. For more than 20 years STI utilized its unique HTS manufacturing process for solutions to maximize capacity utilization and coverage for Tier 1 telecommunications operators. Headquartered in Austin, TX, Superconductor Technologies Inc.'s common stock is listed on the NASDAQ Capital Market under the ticker symbol “SCON.” For more information about STI, please visit http://www.suptech.com.

Investor Relations Contact
Moriah Shilton or Kirsten Chapman
LHA      +1-415-433-3777       invest@suptech.com

– Tables to Follow –


    December 31,
  December 31,
Current Assets:    
Cash and cash equivalents $   713,000   $   5,616,000  
Accounts receivable, net      344,000       —  
Inventory, net      263,000       173,000  
Prepaid expenses and other current assets     76,000       61,000  
Total Current Assets      1,396,000       5,850,000  
Property and equipment, net of accumulated depreciation of $12,948,000 and $12,172,000, respectively      233,000       1,009,000  
Patents, licenses and purchased technology, net of accumulated amortization of $1,071,000 and $1,026,000, respectively     641,000       686,000  
Operating lease assets      152,000       —  
Other assets      60,000       69,000  
Total Assets  $   2,482,000   $   7,614,000  
Current Liabilities:    
Accounts payable  $   527,000   $   313,000  
Accrued expenses      292,000       539,000  
Current lease liabilities      148,000       —  
Total Current Liabilities      967,000       852,000  
Long term lease liabilities      4,000       —  
Other long term liabilities      8,000       17,000  
Total Liabilities      979,000       869,000  
Stockholders’ Equity:    
Preferred stock, $.001 par value, 2,000,000 shares authorized, 328,925 and 330,787 issued and outstanding, respectively     —        —   
Common stock, $.001 par value, 250,000,000 shares authorized, 17,731,893 and 3,270,609 shares issued and outstanding, respectively     18,000       3,000  
Capital in excess of par value      330,458,000       326,486,000  
Accumulated deficit    (328,973,000 )   (319,744,000 )
Total Stockholders’ Equity     1,503,000       6,745,000  
Total Liabilities and Stockholders’ Equity $   2,482,000   $   7,614,000  


    Three Months Ended   Year Ended
  December 31, 2019   December 31, 2018   December 31, 2019   December 31, 2018
  unaudited   unaudited   audited
Commercial product revenues $   5,000      $   —      $   5,000     $   —   
Government contract revenues   383,000        —        540,000       1,556,000  
  Total revenues   388,000        —        545,000       1,556,000  
Costs and expenses:              
  Cost of commercial product revenues   571,000       634,000       3,259,000       2,245,000  
  Cost of government contract revenues   276,000       81,000       303,000       1,210,000  
  Research and development   478,000       697,000       2,353,000       2,352,000  
  Selling, general and administrative   996,000       884,000       3,918,000       3,972,000  
    Total costs and expenses   2,321,000       2,296,000       9,833,000       9,779,000  
Loss from operations   (1,933,000 )     (2,296,000 )     (9,288,000 )     (8,223,000 )
Other Income and Expense              
  Adjustments to fair value of warrant derivatives                     52,000  
  Adjustment to warrant exercise price                     (24,000 )
  Other income   5,000       34,000       59,000       64,000  
    Net loss $ (1,928,000 )   $ (2,262,000 )   $ (9,229,000 )   $ (8,131,000 )
Basic and diluted loss per common share












Weighted average number of common              
  shares issued and outstanding   16,225,832       3,230,975       7,486,584       2,016,869  


  Years Ended December 31,  
    2019       2018       2017    
Net loss $ (9,229,000 ) $   (8,131,000 ) $ (9,527,000 )
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization     820,000       1,015,000       1,885,000  
Stock-based compensation expense     87,000       84,000       341,000  
Adjustments to fair value of warrant derivatives     —       (52,000 )     (99,000 )
Adjustments to warrant exercise price     —        24,000        —   
Changes in assets and liabilities:      
Accounts receivable     (343,000 )     151,000       (143,000 )
Inventory .     (90,000 )     (70,000 )     (34,000 )
Prepaid expenses and other current assets     (16,000 )     22,000       26,000  
Patents and licenses     —       14,000       212,000  
Other assets     9,000        —        27,000  
Accounts payable, accrued expenses and other liabilities     (41,000 )     12,000       (132,000 )
Net cash used in operating activities     (8,803,000 )     (6,931,000 )     (7,444,000 )
Purchase of property and equipment     -       (189,000 )     (152,000 )
Net cash used in investing activities     -       (189,000 )     (152,000 )
Net proceeds from sale of common, prefunded warrants and preferred stock      3,801,000       9,680,000       —   
Net proceeds from exercise of warrants      99,000       —        200,000  
Net cash provided by financing activities     3,900,000       9,680,000       200,000  
Net increase (decrease) in cash and cash equivalents     (4,903,000 )     2,560,000       (7,396,000 )
Cash and cash equivalents at beginning of year     5,616,000       3,056,000       10,452,000  
Cash and cash equivalents at end of year $   713,000   $   5,616,000   $   3,056,000  


Superconductor Technologies Inc. Logo

Source: Superconductor Technologies Inc.

© 2020 Superconductor Technologies Inc.